Wegovy Multipack: How the Pen Schedule Works in the UK

Step 1, Understanding what the Wegovy supply actually looks like

When people search for a Wegovy multipack, they are usually trying to work out whether they can receive several months' worth of pens in one go, or whether they need to reorder each month. The answer depends on your prescriber's assessment at each review point. Wegovy pens are individual pre-filled autoinjectors; a standard box contains four pens, each pre-set at a specific dose strength. That box covers one four-week period, which is why monthly reordering is the norm.

The dose strengths in the licensed UK schedule are 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg, with 7.2 mg now available as an additional maintenance dose following MHRA approval in April 2026. You cannot mix strengths in a single supply run, your pens must match your current prescribed dose. This is not a bureaucratic quirk; giving yourself a higher dose than prescribed significantly raises the risk of gastrointestinal side effects and is not clinically safe.

If you are wondering about nutritional support alongside treatment, it is worth reading about the role of multivitamins during Wegovy treatment, since reduced appetite can affect micronutrient intake over time.

Step 2, Moving through the titration stages (and why you cannot skip them)

Semaglutide is introduced gradually to give your body time to adjust. The standard pathway moves through each dose level roughly every four weeks, though a prescriber may hold you at a particular step for longer if side effects are noticeable. Nausea, mild stomach discomfort and loose stools are most common during the first weeks at any new dose level; they usually ease as your system settles.

This staged approach is the reason a Wegovy multi pack covering the full titration course from start to maintenance would not be straightforward to supply in advance, your suitability for each dose increase needs clinical confirmation before the next pens are issued. At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before dispatch. That review is not a formality; it is the point at which dose progress, tolerance and any concerns are properly assessed.

The full clinical profile of Wegovy, including how the titration schedule has been studied, is covered in more detail on our Wegovy overview page. For a broader look at semaglutide as a medicine, the semaglutide treatment guide is a useful companion read.

Step 3, Receiving and storing your pens correctly

Each set of pens arrives refrigerated in plain, unbranded packaging via tracked next-working-day delivery. Wegovy pens must be stored at 2–8°C until you are ready to use them; there is a limited window for keeping a pen at room temperature, and the exact timeframe is specified in the Patient Information Leaflet that arrives with your supply. That leaflet is the definitive reference, always check it rather than relying on general information online.

Injection sites rotate between the abdomen, thigh and upper arm. Using the same spot repeatedly can cause localised tissue changes that affect absorption, so varying the site each week matters. If you have questions about technique or storage during treatment, nume's aftercare team is available seven days a week.

One practical note many patients mention: ordering around a payday, bank holiday or school holiday is worth thinking about in advance. If you order your Wegovy pack by 12pm on a working day and your prescription is clinically approved, dispatch goes out the same day, but weekends and public holidays fall outside the delivery window, so a little forward planning around those dates avoids any gap in supply.

Step 4, What the 7.2 mg pen changes for ongoing treatment

The MHRA's approval of the dedicated single-dose 7.2 mg Wegovy pen in April 2026 extended the maintenance options available to eligible patients. This pen is licensed for adults with a BMI of 30 or above and is not the starting point, the standard titration still begins at 0.25 mg, working up over several months before a prescriber can consider 7.2 mg as a further step. Trial data reported an average weight reduction of around 20.7% at 72 weeks at this dose, approaching results seen with tirzepatide at its highest strength, according to the MHRA's announcement of the 7.2 mg pen approval.

The NHS covers Wegovy through specialist weight management services under NICE guidance, but waiting lists are often lengthy. Private treatment through a regulated online pharmacy is the route most people use when they want to start without delay. If you want to explore cost context before your consultation, the Wegovy price comparison guide sets out what a legitimate private prescription typically includes. For a wider look at the treatment options available, the weight-loss treatment overview covers the full range. The NHS medicines page for semaglutide also carries clear, patient-level information and is a reliable starting point for understanding what semaglutide involves before your first consultation.

Wegovy is a prescription-only medicine. Clinical assessment by a qualified prescriber is required before any supply, that assessment is what makes the treatment safe and appropriate for you specifically. If you are ready to understand your options, you can start your free consultation with our prescribing team.